Adjuvant

Agriculture Adjuvants Market Size to Reach of US$ 6.2 Billion by 2032

Sales in the global agricultural adjuvants market are expected to grow at a steady 6.2% CAGR over the forecast period, reaching US$ 6.2 Bn by 2032. Increasing industrialization and colonization across ... read more

Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With Emergency Use Authorization In Mongolia

Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to ... read more

Freund's Adjuvant Market: Key Players and Strategies for Future Growth by 2023-2027

The MarketWatch News Department was not involved in the creation of this content. Mar 23, 2023 (The Expresswire) -- The "Freund's Adjuvant Market" research report is a comprehensive study that ... read more

Agriculture Crop Adjuvant Market 2023 - Future Developments, Key Vendors, Regional Analysis, and Industry Scope by 2029

The drivers, restraints, opportunities, and challenges of the Agriculture Crop Adjuvant market are examined in detail after a detailed analysis of the microeconomic and macroeconomic factors affecting ... read more

Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

Administering anti-PD-1 therapy has been shown to improve outcomes in the adjuvant setting but recent research has demonstrated benefit in the neoadjuvant setting due to the potential of activating ... read more

CheckMate 274 Follow-Up Supports the Use of Adjuvant Immunotherapy in Bladder Cancer

Long-term data readouts from trials evaluating immunotherapeutic approaches in bladder cancer are changing the landscape, according to Lindsay Diamond, MSN, AGNP-C, AOCNP. Specifically, extended ... read more

Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma

FRIDAY, March 10, 2023 (HealthDay News) -- For patients with resectable stage III or IV melanoma, event-free survival is longer for those receiving neoadjuvant and adjuvant pembrolizumab compared ... read more

Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma

FRIDAY, March 10, 2023 (HealthDay News) — For patients with resectable stage III or IV melanoma, event-free survival is longer for those receiving neoadjuvant and adjuvant pembrolizumab compared with ... read more

Husain Discusses Role of Osimertinib in Non–Small Cell Lung Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Hatim Husain, MD, discussed data on targeted adjuvant therapy for non–small cell lung cancer. read more

Roundtable Discussion: Pavlick and Participants Review Treatment and AE Management in Melanoma

During a Targeted Oncology™ Case-Based Roundtable™ event, Anna C. Pavlick, DO, MSc, MBA, BSN, discussed first-line therapy for a patient with metastatic melanoma. read more